Published in Women's Health Weekly, January 14th, 2010
"were subdivided according to the use of COX-2 inhibitors after the diagnosis and for >= 6 months. Bivariate analyses were undertaken, and statistically significant variables were included in a multivariate logistic regression model. Eleven percent of patients (74 of 644) who did not use COX-2 inhibitors developed bone metastases compared with 2016 (1 of 48) of those...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly